Markel vs. Skyward: Which Specialty Insurance Stock Is a Better Buy in 2026?
One boasts global diversification and robust free cash flow, while the other pursues rapid growth in niche markets. How do their fundamentals and risks compare?
Markel vs. Skyward: Which Specialty Insurance Stock Is a Better Buy in 2026?
Overview
Insurance stocks can be low volatility growers that offer good income, too. Yet even in the stodgy insurance business, choosing between a seasoned industry leader and an aggressive newcomer is a classic investor dilemma. You might find that Markel Group (NYSE:MKL) and Skyward Specialty Insurance Group (NASDAQ:SKWD) offer two very different paths to growth.
Markel is often compared to a smaller version of a massive conglomerate due to its focus on both underwriting and equity investing. Skyward Specialty Insurance Group is a fast-growing player targeting specific, underserved niches in the market. Investors often weigh these two when deciding between a diversified, established giant and a nimble, high-growth newcomer.
Details
Markel functions as a diverse financial holding company with a primary focus on the specialty insurance industry. It operates sixty-two offices across sixteen countries, serving diverse markets in the United States, Bermuda, and international regions. You should be aware that the top five independent brokers accounted for roughly 37% of gross premiums in 2025, which creates a significant reliance on a few key partners.
Source
Originally published at www.fool.com.
